fatido/E+ through Getty Photos
Lantheus Holdings (NASDAQ:LNTH) introduced on Wednesday that its PET imaging agent MK-6240 met its co-primary endpoints in two pivotal research designed to evaluate its sensitivity and specificity within the analysis of Alzheimer’s illness.
The Bedford, Massachusetts-based firm intends to incorporate these
